NeuroPace Reports Strong Q2 Results and Raises 2023 Outlook
NeuroPace, a commercial-stage medical device company, experienced a surge in its stock price, with shares advancing by 13% to $4.65 ...
Automated Trading Systems
Recent Posts
Best Forex Tools